THNR vs. IHE ETF Comparison
Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to iShares U.S. Pharmaceutical ETF (IHE)
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$23.15
Average Daily Volume
2,584
15
IHE
iShares U.S. Pharmaceutical ETF
IHE Description
The investment seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index (the "underlying index"), which measures the performance of the pharmaceuticals sector of the U.S. equity market. The fund is non-diversified.Grade (RS Rating)
Last Trade
$68.06
Average Daily Volume
33,923
10
Performance
| Period | THNR | IHE |
|---|---|---|
| 30 Days | -11.31% | -4.09% |
| 60 Days | -15.54% | -4.62% |
| 90 Days | -17.09% | -4.63% |
| 12 Months | 18.57% |
THNR: Top Represented Industries & Keywords
IHE: Top Represented Industries & Keywords
Compare ETFs
